Filing Details
- Accession Number:
- 0001209191-20-060558
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-11-25 17:16:11
- Reporting Period:
- 2020-11-25
- Accepted Time:
- 2020-11-25 17:16:11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1623526 | Stoke Therapeutics Inc. | STOK | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1522780 | Md M. Edward Kaye | C/O Stoke Therapeutics, Inc. 45 Wiggins Avenue Bedford MA 01730 | Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-11-25 | 12,848 | $50.00 | 37,152 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
Billionaire Hedge Funds
